


Healthcare Industry News: adalimumab)
News Release - May 27, 2016
AbbVie's HUMIRA(R) (adalimumab) Receives CHMP Positive Opinion to Treat Certain Forms of Non-Infectious Uveitis, a Disease that Can Severely Impact Vision
Source: AbbVie
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
